In line with the previous report that JQ1 cooperates with BCR/ABL TKI in inducing Ph+ CML growth-inhibition [46], we further point out that the synergistic inhibitory effect is predominantly due to the suppression of TXNIP. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.